Side Effects of New Immuno-Modulators (abstract)

Update Item Information
Identifier 20170406_nanos_nosideeffects1_03-abstract
Title Side Effects of New Immuno-Modulators (abstract)
Creator Ore-ofe Oluwaseun Adesina
Affiliation Ruiz Department of Ophthalmology and Visual Science at the McGovern Medical School Houston, Houston, TX
Subject Rheumatologic Drugs; Biologics; Demyelination; Visual Loss
Description Medications used in the management of rheumatologic disorders include therapeutic agents with varying mechanisms of action. The older well known drugs include glucocorticoids, non-steroidal anti-inflammatory drugs and the antimetabolites and cytotoxic medications such as cyclophosphamide, mycophenolate mofetil, methotrexate and azathioprine (disease modifying anti-rheumatic drugs - DMARDs). Of particular interest, however, are the drugs known as biologics. These drugs are not derived from compounds with predictable chemical structures; rather they are complex molecules or mixtures of molecules that are produced by the cells of living microorganisms, plants or animals, often using recombinant DNA.
Date 2017
Language eng
Format application/pdf
Type Text
Source 2017 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2017: Neuro-Ophthalmologic Side Effects of More Recently Used Medications in Treating Cancer, Rheumatologic Disorders, and Multiple Sclerosis
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2013. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6k68c64
Setname ehsl_novel_nam
ID 1273220
Reference URL https://collections.lib.utah.edu/ark:/87278/s6k68c64
Back to Search Results